Achieve Life Sciences Inc (SP4P) — Cash Flow-to-Debt Ratio
Latest as of March 2026:
-0.31x
Achieve Life Sciences Inc (SP4P) has a Cash Flow-to-Debt Ratio of -0.31x as of March 2026, meaning its operating cash flow of €-6.93 Million could theoretically repay 0% of its total liabilities (€22.43 Million) in one year. See Achieve Life Sciences Inc (SP4P) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.31x
Operating CF / Total Liabilities
Operating Cash Flow
€-6.93 Million
EUR
Total Liabilities
€22.43 Million
EUR
Data as of
Mar 2026
Most recent filing
Achieve Life Sciences Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Achieve Life Sciences Inc across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Achieve Life Sciences Inc.
Annual Cash Flow-to-Debt Ratio for Achieve Life Sciences Inc (2016–2025)
Year-by-year debt coverage analysis for Achieve Life Sciences Inc.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.44x | €-49.47 Million | €20.27 Million | ▼ -45.4% |
| 2024 | -1.68x | €-29.77 Million | €17.73 Million | ▼ -42.8% |
| 2023 | -1.18x | €-24.48 Million | €20.82 Million | ▲ +32.1% |
| 2022 | -1.73x | €-37.55 Million | €21.67 Million | ▼ -14.6% |
| 2021 | -1.51x | €-29.44 Million | €19.47 Million | ▲ +66.2% |
| 2020 | -4.47x | €-13.47 Million | €3.01 Million | ▲ +11.0% |
| 2019 | -5.03x | €-15.22 Million | €3.03 Million | ▼ -55.3% |
| 2018 | -3.24x | €-10.62 Million | €3.28 Million | ▲ +28.5% |
| 2017 | -4.52x | €-9.11 Million | €2.01 Million | ▼ -18946.0% |
| 2016 | -0.02x | €-202.00K | €8.50 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.